Tracing subsequent dissemination of a cluster of gonococcal infections caused by an ST1407-related clone harbouring mosaic penA alleles in Taiwan

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 7, 2013, Pages 1567-1571

  Chen, Chun Chen ^a   Yen, Muh Yong ^b   Wong, Wing Wai ^c   Li, Lan Hui ^b   Huang, Yen Lin ^a   Chen, Kuo Wei ^a   Li, Shu Ying ^a  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Antimicrobial resistance; Cephalosporins; Gonorrhoea; PBPs; Penicillin binding proteins; Strain clusters

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFIXIME; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CLINICAL ARTICLE; DISK DIFFUSION; EPSILOMETER TEST; GENETIC POLYMORPHISM; GENOTYPE; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; SYPHILIS; TAIWAN;

EID: 84879494341     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt059     Document Type: Article

References (20)

1. Bolan GA, Sparling PF, Wasserheit JN. The emerging threat of untreatable gonococcal infection. N Engl J Med 2012; 366: 485-7.
2. Ison CA, Hussey J, Sankar KN et al. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill 2011; 16: pii=19833.
3. Allen VG, Mitterni L, Seah C et al. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA 2013; 309: 163-70.
4. Unemo M, Golparian D, Nicholas R et al. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 2012; 56: 1273-80.
5. Unemo M, Golparian D, Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill 2011; 16: pii=19792.
6. Li SY. Global transmission of multiple-drug resistant Neisseria gonorrhoeae strains refractive to cephalosporin treatment. J Formos Med Assoc 2012; 111: 463-4.
7. Huang CT, Yen MY, Wong WW et al. Characteristics and dissemination of mosaic penicillin-binding protein 2-harboring multidrug-resistant Neisseria gonorrhoeae isolates with reduced cephalosporin susceptibility in northern Taiwan. Antimicrob Agents Chemother 2010; 54: 4893-5.
8. Huang CT, Niu J, Liao MH et al. A duplex PCR method to identify mosaic penA gene and predict reduced susceptibility to oral cephalosporins in Neisseria gonorrhoeae. J Microbiol Methods 2010; 83: 257-9.
9. Jolley KA. Multi-locus sequence typing. In: Pollard AJ, Maiden MC, eds. Meningococcal Diseases: Methods and Protocols. Totowa, NJ: Humana Press, 2001; 173-86.
10. Martin IM, Ison CA, Aanensen DM et al. Changing epidemiologic profile of quinolone-resistant Neisseria gonorrhoeae in London. J Infect Dis 2005; 192: 1191-5.
11. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. CLSI, Wayne, PA, USA, 2010.
12. Lee SG, Lee H, Jeong SH et al. Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone. J Antimicrob Chemother 2010; 65: 669-75.
13. Chen CC, Lin KY, Li SY. The role of penicillin-binding protein 2 (PBP2) in the cephalosporin susceptibility of Neisseria gonorrhoeae and the need for consensus in naming of PBP2. J Formos Med Assoc 2012; 111: 665-6.
14. Martin I, Sawatzky P, Allen V et al. Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010. Sex Transm Dis 2012; 39: 316-23.
15. Lindberg R, Fredlund H, Nicholas R et al. Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA. Antimicrob Agents Chemother 2007; 51: 2117-22.
16. Belland RJ, Morrison SG, Ison C et al. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinoloneresistant isolates. Mol Microbiol 1994; 14: 371-80.
17. Whiley DM, Jacobsson S, Tapsall JW et al. Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains. J Antimicrob Chemother 2010; 65: 2543-7.
18. Allen VG, Farrell DJ, Rebbapragada A et al. Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada. Antimicrob Agents Chemother 2011; 55: 703-12.
19. Pandori M, Barry PM, Wu A et al. Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California. Antimicrob Agents Chemother 2009; 53: 4032-4.
20. Golparian D, Hellmark B, Fredlund H et al. Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden. Sex Transm Infect 2010; 86: 454-60.